A drug first developed for cancer has shown promise as a treatment for progeria, a rare and fatal rapid-aging disease in children, and it may have implications in treating cardiovascular problems associated with normal aging
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment